StreetInsider.com News Articles

Conavi Medical Announces Peer-Reviewed Case Report Highlighting Clinical Utility of Hybrid IVUS-OCT Imaging, and Provides Update on Management Team

Thu, 17 Sep 2026 07:00:00 -0400

Latest publication adds to growing body of clinical evidence supporting hybrid IVUS-OCT imaging in complex coronary procedures

Chief Technology Officer Amandeep Thind to lead continued innovation

TORONTO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced the publication of a peer-reviewed case report highlighting the clinical utility of hybrid intravascular ultrasound (“IVUS”) and optical coherence tomography (“OCT”) imaging in guiding treatment decisions following stent placement. The case

Conavi Medical Announces Peer-Reviewed Case Report Highlighting Clinical Utility of Hybrid IVUS-OCT Imaging, and Provides Update on Management Team

Thu, 17 Sep 2026 07:00:00 -0400

Latest publication adds to growing body of clinical evidence supporting hybrid IVUS-OCT imaging in complex coronary procedures

Chief Technology Officer Amandeep Thind to lead continued innovation

Conavi Medical Announces Peer-Reviewed Case Report Highlighting Clinical Utility of Hybrid IVUS-OCT Imaging, and Provides Update on Management Team

Thu, 17 Sep 2026 07:00:00 -0400

Latest publication adds to growing body of clinical evidence supporting hybrid IVUS-OCT imaging in complex coronary procedures

Chief Technology Officer Amandeep Thind to lead continued innovation

Conavi Medical Announces Peer-Reviewed Case Report Highlighting Clinical Utility of Hybrid IVUS-OCT Imaging, and Provides Update on Management Team

Thu, 17 Sep 2026 07:00:00 -0400

Latest publication adds to growing body of clinical evidence supporting hybrid IVUS-OCT imaging in complex coronary procedures

Chief Technology Officer Amandeep Thind to lead continued innovation

Conavi Medical Announces Media and Digital Marketing Agreements

Fri, 04 Sep 2026 18:02:00 -0400

TORONTO, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced that it has entered into media and digital marketing agreements to support increased market awareness of the Company.

Media and Digital Marketing Agreements

Conavi Medical has entered into a media services agreement with Market One Media Group (“Market One”). Market One, with offices in Vancouver and Toronto, is a multiplatform media solution for the capital markets operating in

Conavi Medical Announces Media and Digital Marketing Agreements

Fri, 04 Sep 2026 18:02:00 -0400

Media and Digital Marketing Agreements

Form D Conavi Medical Corp.

Mon, 31 Aug 2026 07:01:00 -0400

si-local-file:///var/storage/secattach/20260831/27000877.html

Conavi Medical Reports Fiscal Third Quarter 2026 Results and Operational Highlights

Thu, 27 Aug 2026 08:03:00 -0400

Net loss for Fiscal Q3 2026 was $6.3 million (Fiscal Q3 2025 - $3.6 million) reflecting continued investment in research and development activities of $4.4 million (Fiscal Q3 2025 - $3.2 million)
Ended Fiscal Q3 2026 with $0.9M in cash and cash equivalents (Fiscal Q4 2025 - $5.8 million) and on August 12, 2026 closed $10 million public offering
Received $1.25 Million Ontario Life Sciences Scale-Up Fund Milestone Payment
Achieved U.S. FDA 510(k) Clearance for Next-Generation Hybrid IVUS-OCT Imaging System
Added to Clinical Evidence Supporting Hybrid IVUS-OCT Imaging